Erratum to New perspectives in cell delivery systems for tissue regeneration: Natural-derived injectable hydrogels(J Appl Biomater Funct Mater), (2012), 10, 2, (e67-e81), 10.5301/JABFM.2012.9418);New perspectives in cell delivery systems for tissue regeneration: Natural-derived injectable hydrogels

Journal of Applied Biomaterials and Functional Materials

Volumn 10, Issue 2, 2012, Pages 67-81

  Munarin, Fabiola ^a   Petrini, Paola ^a   Bozzini, Sabrina ^a   Tanzi, Maria Cristina ^a  

^a POLITECNICO DI MILANO   (Italy)

Author keywords

Biomaterials; Cell delivery; Injectable hydrogels; Microspheres; Natural polymers; Tissue regeneration

Indexed keywords

BIOCOMPATIBILITY; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; HYDROGELS; NATURAL POLYMERS; TARGETED DRUG DELIVERY; TISSUE;

ACTIVE BIOMOLECULES; CELL DELIVERY; CELL DELIVERY SYSTEMS; CONTROLLED RELEASE; DELIVERY SYSTEMS; INJECTABLE HYDROGELS; PHYSICOCHEMICAL PROPERTY; PROTEIN GENES; REGENERATIVE MEDICINE; SUSTAINED RELEASE;

TISSUE REGENERATION;

AGAROSE; ALGINIC ACID; ARGINYLGLYCYLASPARTYLSERINE; BIOMATERIAL; CALCIUM PHOSPHATE CEMENT; CEMENT; CHITOSAN; COLLAGEN; DRUG CARRIER; FIBRIN; GELATIN; HYALURONIC ACID; MICROSPHERE; POLOXAMER; POLYMER; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE REGENERATION; ADIPOSE TISSUE TRANSPLANTATION; ANGIOGENESIS; ARTIFICIAL EMBOLISM; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; BIODEGRADABILITY; BIOSENSOR; BONE DISEASE; BONE REGENERATION; BONE REMODELING; CARTILAGE REGENERATION; CELL ADHESION; CELL DELIVERY SYSTEM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELL VIABILITY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; HEART MUSCLE REVASCULARIZATION; HEMATOPOIETIC STEM CELL; HEMIFACIAL ATROPHY; HUMAN; HYDROGEL; IMMOBILIZED CELL; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK REGENERATION; MESENCHYMAL STEM CELL; MINIMALLY INVASIVE SURGERY; MORTALITY; NERVE REGENERATION; NEURAL RETINAL STEM CELL TRANSPLANTATION; PLASTIC SURGERY; POLAND SYNDROME; RETINA DISEASE; REVIEW; SOFT TISSUE RECONSTRUCTION; SOLUBILIZATION; TISSUE REGENERATION; TISSUE TRANSPLANTATION;

EID: 84870294148     PISSN: None     EISSN: 22808000     Source Type: Journal    
DOI: 10.5301/JABFM.2013.11194     Document Type: Erratum

References (198)

1. Fuchs KH. Minimally invasive surgery. Endoscopy 2002; 34: 154-9.
2. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002; 54: 3-12.
3. Wylie RG, Ahsan S, Aizawa Y, Maxwell KL, Morshead CM, Shoichet MS. Spatially controlled simultaneous patterning of multiple growth factors in three-dimensional hydrogels. Nat Mater 2011;10: 799-806.
4. West JL. Protein-patterned hydrogels: Customized cell microenvironments. Nat Mater 2011; 10: 727-9.
5. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008; 68: 34-45.
6. Kopeček J. Hydrogel biomaterials: A smart future? Biomaterials 2007; 28: 5185-92.
7. Vodná L, Bubeníková S, Bakoscaron D. Chitosan Based Hydrogel Microspheres as Drug Carriers. Macromol Biosci 2007; 7: 629-34.
8. Khademhosseini A, Langer R. Microengineered hydrogels for tissue engineering. Biomaterials 2007; 28: 5087-92.
9. Möller L, Krause A, Dahlmann J, Gruh I, Kirschning A, Dräger G. Preparation and evaluation of hydrogel-composites from methacrylated hyaluronic acid, alginate, and gelatin for tissue engineering. Int J Artif Organs. 2011; 34: 93-102.
10. Negredo E, Puig J, Aldea D, et al. Four-Year Safety with Polyacrylamide Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy. AIDS Res Hum Retroviruses 2009; 25: 451-5.
11. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 2008; 3: 153-9.
12. Scarano A, Carinci F, Piattelli A. Lip augmentation with a new filler (agarose gel): a 3-year follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: e11-e15.
13. Falcone SJ, Doerfler AM, Berg RA. Novel Synthetic Dermal Fillers Based on Sodium Carboxymethylcellulose: Comparison with Crosslinked Hyaluronic Acid-Based Dermal Fillers. Dermatol Surg 2007; 33: 136-43.
14. Iafisco M, Varoni E, Battistella E, et al. The cooperative effect of size and crystallinity degree on the resorption of biomimetic hydroxyapatite for soft tissue augmentation. Int J Artif Organs 2010; 33: 765-74.
15. Lose G, Mouritsen L, Nielsen JB. A new bulking agent (polyacrylamide hydrogel) for treating stress urinary incontinence in women. BJU Int 2006; 98: 100-4.
16. Ramseyer P, Meagher-Villemure K, Burki M, Frey P. (Poly) acrylonitrile-based hydrogel as a therapeutic bulking agent in urology. Biomaterials 2007; 28: 1185-90.
17. Yu RN, Roth DR., Treatment of Vesicoureteral Reflux Using Endoscopic Injection of Nonanimal Stabilized Hyaluronic Acid/Dextranomer Gel: Initial Experience in Pediatric Patients by a Single Surgeon. Pediatrics 2006; 118: 698-703.
18. Jia X, Burdick JA, Kobler J, et al. Synthesis and Characterization of in Situ Cross-Linkable Hyaluronic Acid-Based Hydrogels with Potential Application for Vocal Fold Regeneration. Macromolecules 2004; 37: 3239-48.
19. Rosen CA Gartner-Schmidt J, Casiano R, et al. Vocal fold augmentation with calcium hydroxylapatite: Twelvemonth report. Laryngoscope 2009; 119: 1033-41.
20. Park HJ, Kang HS, Han MH, Jeon P, Yoo DS, Lee TH. Embolization of Intracranial Aneurysms with HydroSoft Coils: Results of the Korean Multicenter Study. AJNR Am J Neuroradiol 2011; 32: 1756-61.
21. Kang QK, An YH, Moreira PL, Demcheva MV, Vournakis JN. Arterial Embolization Using Poly-NAcetyl Glucosamine Gel in a Rat Kidney Model. Anat Rec A Discov Mol Cell Evol Biol 2005; 284: 454-9.
22. Shibata H, Heo YJ, Okitsu T, Matsunaga Y, Kawanishi T, Takeuchi S. Injectable hydrogel microbeads for fluorescence-based in vivo continuous glucose monitoring. Proc Natl Acad Sci U S A 2010; 107: 17894-98.
23. Ulijn RV, Bibi N, Jayawarna V, et al. Bioresponsive Hydrogels. Mater Today (Kidlington) 2007; 10: 40-8.
24. Gawel K, Barriet D, Sletmoen M, Stokke BT. Responsive Hydrogels for Label-Free Signal Transduction within Biosensors. Sensors (Basel) 2010; 10: 4381-409.
25. Hendrickson GR, Lyon LA. Bioresponsive hydrogels for sensing applications. Soft Matter 2009; 5: 29-35.
26. Munarin F, Guerreiro SS, Grellier MA, et al. Pectin-based injectable biomaterials for bone tissue engineering. Biomacromolecules 2011; 12: 568-77.
27. Giordano C, Albani D, Gloria A, et al. Nanocomposites for neurodegenerative diseases: hydrogel-nanoparticle combinations for a challenging drug delivery. Int J Artif Organs 2011; 34: 1115-27.
28. Asmus LR, Gurny R, Möller M. Solutions for lipophilic drugs: A biodegradable polymer acting as solvent, matrix, and carrier to solve drug delivery issues. Int J Artif Organs 2011; 34: 238-42.
29. Bidarra SJ, Barrias CC, Fonseca KB, Barbosa MA, Soares RA, Granja PL. Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 2011; 32: 7897-904.
30. Fonseca KB, Bidarra S, Oliveira MJ, Granja PL, Barrias CC. Molecularly designed alginate hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments. Acta Biomater 2011; 7: 1674-82.
31. Goepfert C, Lutz V, Lünse S, et al. Evaluation of cartilage specific matrix synthesis of human articular chondrocytes after extended propagation on microcarriers by image analysis. Int J Artif Organs 2010; 33: 204-19.
32. Bigucci F, Luppi B, Cerchiara T, et al. Chitosan/pectin polyelectrolyte complexes: Selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur J Pharm Sci 2008; 35: 435-441.
33. Coviello T, Matricardi P, Marianecci C, Alhaique F. Polysaccharide hydrogels for modified release formulations. J Control Release 2007; 119: 5-24.
34. El-Hag Ali A, Abd El-Rehim HA, Kamal H, Hegazy DEA. Synthesis of Carboxymethyl Cellulose Based Drug Carrier Hydrogel Using Ionizing Radiation for Possible Use as Site Specific Delivery System. J Macromol Sci, Part A: Pure Appl Chem 2008; 45: 628-34.
35. Kusanagi M, Matsui O, Sanada J, et al. Hydrogel-Mediated Release of Basic Fibroblast Growth Factor From a Stent-Graft Accelerates Biological Fixation With the Aortic Wall in a Porcine Model. J Endovasc Ther 2007; 14: 785-93.
36. Asnaghi MA, Candiani G, Farè S, et al. Trends in biomedical engineering: focus on Regenerative Medicine. J Appl Biomater Biomech 2011; 9: 73-86.
37. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 2004; 10: 42-50.
38. Müller I, Lymperi S, Dazzi F. Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr Opin Organ Transplant 2008; 13: 639-44.
39. Huang Y, Enzmann V, Ildstad S. Stem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases. Stem Cell Rev 2011; 7: 434-45.
40. Ghodsizad A, Loebe M, Piechaczek C, et al. Surgical therapy of end-stage heart failure: understanding cellmediated mechanisms interacting with myocardial damage. Int J Artif Organs. 2011; 34: 529-45.
41. Kim WG, Park JJ, Chung DH, Na CY. Autologous cardiomyocyte transplantation in an ovine myocardial infarction model. Int J Artif Organs 2002; 25: 61-6.
42. Gojo S, Gojo N, Takeda Y, et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 2003; 288: 51-9.
43. Makkar RR, Price MJ, Lill M, et al. Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction. J Cardiovasc Pharmacol Ther 2005; 10: 225-33.
44. Evangelista MB, Hsiong SX, Fernandes R, et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 2007; 28: 3644-55.
45. Grellier M, Granja PL, Fricain J, et al. The effect of the coimmobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009; 30: 3271-8.
46. Kim WG, Park JK, Moon HK, Roh JR. Autologous cardiomyocyte transplantation using a biodegradable polymer scaffold. Int J Artif Organs 2003; 26: 401-5.
47. Kharenko E, Larionova N, Demina N. Mucoadhesive drug delivery systems (Review). Pharm Chem J 2009; 43: 200-8. [AQ: please check Journal abbreviation]
48. Peppas NA, Sahlin JJ. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 1996; 17: 1553-61.
49. Vert M. Degradable polymers in medicine: updating strategies and terminology. Int J Artif Organs 2011; 34: 76-83.
50. Munarin F, Petrini P, Farè S, Tanzi MC. Structural properties of polysaccharide-based microcapsules for soft tissue regeneration. J Mater Sci Mater Med 2010; 21: 365-75.
51. Tschon M, Fini M, Giavaresi G, et al. In vitro and in vivo behaviour of biodegradable and injectable PLA/PGA copolymers related to different matrices. Int J Artif Organs 2007; 30: 352-62.
52. Piskin E. Biodegradable polymeric matrices for bioartificial implants. Int J Artif Organs 2002; 25: 434-40.
53. Hunt N, Grover L. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 2010; 32: 733-42.
54. Huss R, Dunant P, Heil M. Adult stem cells from peripheral blood for cell, tissue and organ repair. Int J Artif Organs 2002; 25: 611-2.
55. Cancedda R, Dozin B, Giannoni P, Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003 22: 81-91.
56. Lucas PA. Stem cells for mesothelial repair: An understudied modality. Int J Artif Organs 2007; 30: 550-6.
57. Peterson L, Minas T, Brittberg M, Lindahl A. Treatment of Osteochondritis Dissecans of the Knee with Autologous Chondrocyte Transplantation: Results at Two to Ten Years. J Bone Joint Surg Am 2003; 85: 17-24.
58. Fan H, Tao H, Wu Y, Hu Y, Yan Y, Luo Z. TGF-b3 immobilized PLGA-gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration. J Biomed Mater Res A 2010; 95: 982-92.
59. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF- β1 and chondrocytes via injectable, biodegradablehydrogels for cartilage tissue engineering applications. Biomaterials 2005; 26: 7095-103.
60. Liu Y, Shu XZ, Prestwich GD. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 2006; 12: 3405-16.
61. Park H, Temenoff JS, Tabata Y, Caplan AI, Mikos AG. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007; 28: 3217-27.
62. Brochhausen C, Zehbe R, Gross U, Schubert H, Kirkpatrick CJ. Perspectives for the tissue engineering of cartilage from a biological and biomaterial point of view. J Appl Biomater Biomech 2007; 5: 70-81.
63. Lind M, Larsen A, Clausen C, Osther K, Everland H. Cartilage repair with chondrocytes in fibrin hydrogel and MPEG polylactide scaffold: an in vivo study in goats. Knee Surg Sports Traumatol Arthrosc 2008; 16: 690-8.
64. Park H, Temenoff JS, Tabata Y, et al. Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A 2009; 88: 889-97.
65. Kim D, Heo S, Shin J, et al. Preparation of thermosensitive gelatin-pluronic copolymer for cartilage tissue engineering. Macromolecular Research 2010; 18: 387-91.
66. Salgado CL, Sanchez EM, Zavaglia CA, Almeida AB, Granja PL. Injectable biodegradable polycaprolactonesebacic Acid gels for bone tissue engineering. Tissue Eng Part A 2012; 18: 137-46.
67. Lee Y, Chung HJ, Yeo S, et al. Thermo-sensitive, injectable, and tissue adhesive sol-gel transition hyaluronic acid/ pluronic composite hydrogels prepared from bio-inspired catechol-thiol reaction. Soft Matter 2010; 6: 977-83.
68. Park H, Lee KY. Facile control of RGD-alginate/hyaluronate hydrogel formation for cartilage regeneration. Carbohydr Polym 2011; 86: 1107-12.
69. Fussenegger M, Meinhart J, Höbling W, Kullich W, Funk S, Bernatzky G. Stabilized Autologous Fibrin-Chondrocyte Constructs for Cartilage Repair in Vivo. Ann Plast Surg 2003; 51: 493-8.
70. Stevens MM, Qanadilo HF, Langer R, Shastri VP A rapidcuring alginate gel system: Utility in periosteum-derived cartilage tissue engineering. Biomaterials 2004; 25: 887-94.
71. Choi BH, Woo J, Min B, Park SR. Low-intensity ultrasound stimulates the viability and matrix gene expression of human articular chondrocytes in alginate bead culture. J Biomed Mater Res A 2006; 79A: 858-64.
72. Mehlhorn AT, Schmal H, Kaiser S, et al. Mesenchymal stem cells maintain TGF-beta-mediated chondrogenic phenotype in alginate bead culture. Tissue Eng 2006; 12: 1393-403.
73. Hoemann CD, Sun J, Légaré A, McKee MD, Buschmann MD. Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. Osteoarthritis Cartilage 2005; 13: 318-29.
74. Schagemann JC, Mrosek EH, Landers R, Kurz H, Erggelet C. Morphology and Function of Ovine Articular Cartilage Chondrocytes in 3-D Hydrogel Culture. Cells Tissues Or- gans 2006; 182: 89-97.
75. Chen J, Cheng T. Thermo-Responsive Chitosan-graftpoly(N-isopropylacrylamide) Injectable Hydrogel for Cultivation of Chondrocytes and Meniscus Cells. Macromol Biosci 2006; 6: 1026-39.
76. Ki HB, Jun JY, Tae GP. Fabrication of hyaluronic acid hydrogel beads for cell encapsulation. Biotechnol Prog 2006; 22: 297-302.
77. Chang J, Rasamny JJ, Park SS. Injectable tissue-engineered cartilage using a fibrin sealant. Arch Facial Plast Surg 2007; 9: 161-6.
78. Dare EV, Vascotto SG, Carlsson D, Hincke MT, Griffith M. Differentiation of a fibrin gel encapsulated chondrogenic cell line. Int J Artif Organs 2007; 30: 619-27.
79. Guo X, Park H, Liu G, et al. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 2009; 30: 2741-52.
80. Haider M, Cappello J, Ghandehari H, Leong KW. In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm Res 2008; 25: 692-9.
81. Marsich E, Borgogna M, Donati I, et al. Alginate/lactosemodified chitosan hydrogels: A bioactive biomaterial for chondrocyte encapsulation. J Biomed Mater Res A 2008; 84A: 364-76.
82. Funayama A, Niki Y, Matsumoto H, et al. Repair of fullthickness articular cartilage defects using injectable type II collagen gel embedded with cultured chondrocytes in a rabbit model. J Orthop Sci 2008; 13: 225-32.
83. Hui TY, Cheung KMC, Cheung WL, Chan D, Chan BP. In vitro chondrogenic differentiation of human mesenchymal stem cells in collagen microspheres: Influence of cell seeding density and collagen concentration. Biomaterials 2008; 29: 3201-12.
84. Lu G, Sheng B, Wei Y, et al. Collagen nanofiber-covered porous biodegradable carboxymethyl chitosan microcarriers for tissue engineering cartilage. Eur Polym J 2008; 44: 2820-9.
85. Tan H, Chu CR, Payne KA, Marra KG. Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 2009; 30: 2499-506.
86. Gong Y, Wang C, Lai RC, Su K, Zhang F, Wang D. An improved injectable polysaccharide hydrogel: modified gellan gum for long-term cartilage regeneration in vitro. J Mater Chem 2009; 19: 1968-77.
87. Oliveira JT, Santos TC, Martins L, et al. Performance of new gellan gum hydrogels combined with human articular chondrocytes for cartilage regeneration when subcutaneously implanted in nude mice. J Tissue Eng Regen Med 2009; 3: 493-500.
88. Oliveira JT, Gardel LS, Rada T, Martins L, Gomes ME, Reis RL. Injectable gellan gum hydrogels with autologous cells for the treatment of rabbit articular cartilage defects. J Orthop Res 2010; 28: 1193-9.
89. Fan J, Gong Y, Ren L, Varshney RR, Cai D, Wang D. In vitro engineered cartilage using synovium-derived mesenchymal stem cells with injectable gellan hydrogels. Acta Biomater 2010; 6: 1178-85.
90. Lee H, Park TG. Photo-crosslinkable, biomimetic, and thermo-sensitive pluronic grafted hyaluronic acid copolymers for injectable delivery of chondrocytes. J Biomed Mater Res A 2009; 88: 797-806.
91. Dobratz EJ, Kim SW, Voglewede A, Park SS. Injectable Cartilage. Arch Facial Plast Surg 2009; 11: 40-7.
92. Zhao M, Li L, Zhou C, Lu L. Preparation and characterization of t calcium alginate hydrogels as injectable cartilage scaffolds. J Funct Biomater 2010; 41: 1353-6.
93. Endres M, Wenda N, Woehlecke H, et al. Microencapsulation and chondrogenic differentiation of human mesenchymal progenitor cells from subchondral bone marrow in Ca-alginate for cell injection. Acta Biomater 2010; 6: 436-44.
94. Igarashi T, Iwasaki N, Kasahara Y, Minami A. A cellular implantation system using an injectable ultra-purified alginate gel for repair of osteochondral defects in a rabbit model. J Biomed Mater Res A 2010; 94A: 844-55.
95. Igarashi T, Iwasaki N, Kawamura D, et al. Repair of articular cartilage defects with a novel injectable in situ forming material in a canine model. J Biomed Mater Res A 2012; 100: 180-7.
96. Bian L, Zhai DY, Tous E, Rai R, Mauck RL, Burdick JA. Enhanced MSC chondrogenesis following delivery of TGF-Î23 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials 2011; 32: 6425-34.
97. Sa-Lima H, Caridade SG, Mano JF, Reis RL. Stimuli-responsive chitosan-starch injectable hydrogels combined with encapsulated adipose-derived stromal cells for articular cartilage regeneration. Soft Matter 2010; 6: 5184-95.
98. Jin R, Moreira Teixeira LS, Krouwels A, et al. Synthesis and characterization of hyaluronic acid-poly(ethylene glycol) hydrogels via Michael addition: An injectable biomaterial for cartilage repair. Acta Biomater 2010; 6: 1968-977.
99. Jin R, Moreira Teixeira LS, Dijkstra PJ, van Blitterswijk CA, Karperien M, Feijen J. Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels. J Control Release 2011; 152: 186-95.
100. Wennink JWH, Niederer K, Bochyska AI, et al. Injectable Hydrogels by Enzymatic Co-Crosslinking of Dextran and Hyaluronic Acid Tyramine Conjugates. Macromol Symp 2011; 309-310: 213-21.
101. Kim BS, Choi JS, Kim J., Yeo TY, Cho YW. Improvement of stem cell viability in hyaluronic acid hydrogels using dextran microspheres. J Biomater Sci Polym Ed 2010; 21: 1701-11.
102. Saw K, Anz A, Merican S, et al. Articular Cartilage Regeneration With Autologous Peripheral Blood Progenitor Cells and Hyaluronic Acid After Arthroscopic Subchondral Drilling: A Report of 5 Cases With Histology. Arthros copy 2011; 27: 493-506.
103. Lin L, Chang SJ, Lin CY, et al. Repair of Chondral Defects With Allogenous Chondrocyte-Seeded Hyaluronan/Collagen II Microspheres in a Rabbit Model. J Artif Organs 2011; 36: E102-E9.
104. Merceron C, Portron S, Masson M, et al. The effect of two and three dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel. Cell Transplant 2011; 20: 1575-88.
105. Azami M, Samadikuchaksaraei A, Poursamar SA. Synthesis and characterization of a laminated hydroxyapatite/gelatin nanocomposite scaffold with controlled pore structure for bone tissue engineering. Int J Artif Organs 2010; 33: 86-95.
106. Alsberg E, Anderson KW, Albeiruti A, Franceschi RT, Mooney DJ. Cell-interactive Alginate Hydrogels for Bone Tissue Engineering. J Dent Res 2001; 80: 2025-9.
107. Payne RG, Yaszemski MJ, Yasko AW, Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials 2002; 23: 4359-71.
108. Spitzer R, Perka C, Lindenhayn K, Zippel H. Matrix engineering for osteogenic differentiation of rabbit periosteal cells using b-tricalcium phosphate particles in a threedimensional fibrin culture. J Biomed Mater Res 2002; 59: 690-6.
109. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003; 24: 2497-502.
110. Park D, Choi B, Zhu S, Huh J, Kim B, Lee S. Injectable bone using chitosan-alginate gel/mesenchymal stem cells/BMP-2 composites. J Craniomaxillofac Surg 2005; 33: 50-4.
111. Kneser U, Voogd A, Ohnolz J, et al. Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute. Cells Tissues Organs 2005; 179: 158-69.
112. Abbah SA, Lu WW, Chan D, et al. In vitro evaluation of alginate encapsulated adipose-tissue stromal cells for use as injectable bone graft substitute. Biochem Biophys Res Commun 2006; 347: 185-91.
113. Lerouxel E, Weiss P, Giumelli B, et al. Injectable calcium phosphate scaffold and bone marrow graft for bone reconstruction in irradiated areas: an experimental study in rats. Biomaterials 2006; 27: 4566-72.
114. Fellah BH, Weiss P, Gauthier O, et al. Bone repair using a new injectable self-crosslinkable bone substitute. J Orthop Res 2006; 24: 628-35.
115. Kruyt MC, Persson C, Johansson G, Dhert WJ, de Bruijn JD. Towards injectable cell-based tissue-engineered bone: the effect of different calcium phosphate microparticles and pre-culturing. Tissue Eng 2006; 12: 309-17.
116. Nair LS, Starnes T, Ko JK, Laurencin CT. Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications. Biomacromolecules 2007; 8: 3779-85.
117. Abbah SA, Lu WW, Chan D, et al. Osteogenic behavior of alginate encapsulated bone marrow stromal cells: An in vitro study. J Mater Sci Mater Med 2008; 19: 2113-9.
118. Bidarra SJ, Barrias CC, Barbosa MA, Soares R, Granja PL. Immobilization of Human Mesenchymal Stem Cells within RGD-Grafted Alginate Microspheres and Assessment of Their Angiogenic Potential. Biomacromolecules 2010; 11: 1956-64.
119. Xu HHK, Weir MD, Simon CG. Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. Dent Mater 2008; 24: 1212-22.
120. Hashimoto Y, Adachi S, Matsuno T, et al. Effect of an injectable 3D scaffold for osteoblast differentiation depends on bead size. Biomed Mater Eng 2009; 19: 391-400.
121. Xu HHK, Zhao L, Weir MD. Stem Cell-Calcium Phosphate Constructs for Bone Engineering. J Dent Res 2010; 89: 1482-8.
122. Weir MD, Xu HHK. Osteoblastic induction on calcium phosphate cement-chitosan constructs for bone tissue engineering. J Biomed Mater Res A 2010; 94A: 223-33.
123. Zhao L, Weir MD, Xu HHK. An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 2010; 31: 6502-10.
124. Park S, Tofighi A, Wang X, et al. Calcium phosphate combination biomaterials as human mesenchymal stem cell delivery vehicles for bone repair. J Biomed Mater Res B Appl Biomater 2011; 97 B: 235-44.
125. Stephan SJ, Tholpady SS, Gross B, et al. Injectable tissueengineered bone repair of a rat calvarial defect. Laryngoscope 2010; 120: 895-901.
126. Qi B, Yu A, Zhu S, Chen B, Li Y. The preparation and cytocompatibility of injectable thermosensitive chitosan/ poly(vinyl alcohol) hydrogel. J Huazhong Univ Sci Technolog Med Sci 2010; 30: 89-93.
127. Chan BP, Hui TY, Wong MY, Yip KHK, Chan GCF. Mesenchymal stem cell-encapsulated collagen microspheres for bone tissue engineering. Tissue Engineering Part C Methods 2010; 16: 225-35.
128. Tan R, She Z, Wang M, Fang Z, Liu Y, Feng Q. Thermosensitive alginate-based injectable hydrogel for tissue engineering. Carbohydr Polym 2012; 87: 1515-21.
129. Zhou H, Xu HHK. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering. Biomaterials 2011; 32: 7503-13.
130. Mishra D, Bhunia B, Banerjee I, Datta P, Dhara S, Maiti TK. Enzymatically crosslinked carboxymethyl-chitosan/ gelatin/nano- hydroxyapatite injectable gels for in situ bone tissue engineering application. Mat Sci Eng C Mater Biol Appl 2011; 31: 1295-304.
131. Huang Z, Yu B, Feng Q, Li S, Chen Y, Luo L. In situ-forming chitosan/nano-hydroxyapatite/collagen gel for the delivery of bone marrow mesenchymal stem cells. Carbohydr Polym 2011; 85: 261-7.
132. Sun B, Ma W, Su F, et al. The osteogenic differentiation of dog bone marrow mesenchymal stem cells in a thermosensitiveinjectable chitosan/collagen/β-glycerophosphate hydrogel: in vitro and in vivo. J Mater Sci Mater Med 2011; 22: 2111-8.
133. Liao HT, Chen CT, Chen JP. Osteogenic differentiation and ectopic bone formation of canine bone marrow-derived mesenchymal stem cells in injectable thermo-responsive polymer hydrogel. Tissue Eng Part C Methods 2011; 17: 1139-49.
134. Tenorio DMH, Scaletta C, Jaccoud S, et al. Human fetal bone cells in delivery systems for bone engineering. J Tissue Eng Regen Med 2011; 5: 806-14.
135. Zhao Z, Hao C, Zhao H, Liu J, Shao L. Injectable allogeneic bone mesenchymal stem cells: A potential minimally invasive therapy for atrophic nonunion., Med Hypotheses 2011 11; 77: 912-3.
136. Munarin F, Giuliano L, Bozzini S, Tanzi MC, Petrini P. Mineral phase deposition on pectin microspheres. Mat Sci Eng C Mater Biol Appl 2010; 30: 491-6.
137. Bigi A, Torricelli P, Fini M, et al. A biomimetic gelatincalcium phosphate bone cement. Int J Artif Organs 2004; 27: 664-73.
138. Munarin F, Petrini P, Tanzi MC, Barbosa MA, Granja PL. Biofunctional chemically modified pectin for cell delivery. Soft Matter 2012; 8: 4731-9.
139. Perale G, Bianco F, Giordano C, Matteoli M, Masi M, Cigada A. Engineering injured spinal cord with bone marrow-derived stem cells and hydrogel-based matrices: a glance at the state of the art. J Appl Biomater Biomech 2008; 6: 1-8.
140. Perka C, Arnold U, Spitzer RS, Lindenhayn K. The use of fibrin beads for tissue engineering and subsequential transplantation. Tissue Eng 2001; 7: 359-61.
141. Masuda K, Miyabayashi T, Meachum SH, Eurell TE. Proliferation of canine intervertebral disk chondrocytes in three-dimensional alginatemicrosphere culture. J Vet Med Sci 2002; 64: 79-82.
142. Crevensten G, Walsh AJL, Ananthakrishnan D, et al. Intervertebral disc cell therapy for regeneration: Mesenchymal stem cell implantation in rat intervertebral discs. Ann Biomed Eng 2004; 32: 430-4.
143. Mwale F, Iordanova M, Demers CN, Steffen T, Roughley P, Antoniou J. Biological evaluation of chitosan salts cross-linked to genipin as a cell scaffold for disk tissue engineering. Tissue Eng 2005; 11: 130-40.
144. Dang JM, Sun DDN, Shin-Ya Y, Sieber AN, Kostuik JP, Leong KW. Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and interverte- bral disk cells. Biomaterials 2006; 27: 406-18.
145. Chan BP, Hui TY, Yeung CW, Li J, Mo I, Chan GCF. Selfassembled collagen-human mesenchymal stem cell microspheres for regenerative medicine. Biomaterials 2007; 28: 4652-66.
146. Abbah SA, Lu WW, Peng SL, et al. Extracellular matrix stability of primary mammalian chondrocytes and intervertebral disc cells cultured in alginate-based microbead hydrogels. Cell Transplant 2008; 17: 1181-92.
147. Shen B, Wei A, Tao H, Diwan AD, Ma DD. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A 2009; 15: 1311-20.
148. Halloran DO, Grad S, Stoddart M, Dockery P, Alini M, Pandit AS. An injectable cross-linked scaffold for nucleus pulposus regeneration. Biomaterials 2008; 29: 438-47.
149. Collin EC, Grad S, Zeugolis DI, et al. An injectable vehicle for nucleus pulposus cell-based therapy. Biomaterials 2011; 32: 2862-70.
150. Finch GD, Dawe CJ. Hemiatrophy. J Pediatr Orthop 2003; 23: 99-101.
151. Fokin AA, Robicsek F. Poland's syndrome revisited. Ann Thorac Surg 2002; 74: 2218-25.
152. Peer LA. The neglected "Free fat graft," Its behavior and clinical use. Am J Surg 1956; 92: 40-7.
153. De Girolamo L, Sartori MF, Arrigoni E, et al. Human adipose-derived stem cells as future tools in tissue regeneration: Osteogenic differentiation and cell-scaffold interaction. Int J Artif Organs 2008; 31: 467 -79
154. Yu SC, Park S, Suh H. Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 2005; 26: 5855-63.
155. Kang SW, Seo SW, Choi CY, Kim BS. Porous poly(lacticco-glycolic acid) microsphere as cell culture substrate and cell transplantation vehicle for adipose tissue engineering. Tissue Eng Part C Methods 2008; 14: 25-34.
156. Tanzi MC, Farè S. Adipose tissue engineering: state of the art, recent advances and innovative approaches. Expert Rev Med Devices 2009; 6: 533-51.
157. Marler JJ, Guha A, Rowley J, et al. Soft-Tissue Augmentation with Injectable Alginate and Syngeneic Fibroblasts. Plast Reconstr Surg 2000;105: 2049-58.
158. Wechselberger G, Russell RC, Neumeister MW, Schoeller T, Piza-Katzer H, Rainer C. Successful Transplantation of Three Tissue-Engineered Cell Types Using Capsule Induction Technique and Fibrin Glue as a Delivery Vehicle. Plast Reconstr Surg 2002; 110: 123-9.
159. Kim BS, Choi JS, Kim J., Yeo TY, Cho YW. Improvement of stem cell viability in hyaluronic acid hydrogels using dextran microspheres. J Biomater Sci Polym Ed 2010; 21: 1701-11.
160. Kim WS, Mooney D, Arany PR, Lee K, Huebsch N, Kim J. Adipose Tissue Engineering using injectable, oxidized alginate hydrogels. Tissue Eng Part A 2012; 18: 737-43.
161. Choi JS, Yang H, Kim BS, et al. Human extracellular matrix (ECM) powders for injectable cell delivery and adipose tissue engineering. J Control Release 2009; 139: 2-7.
162. Young DA, Ibrahim DO, Hu D, Christman KL. Injectable hydrogel scaffold from decellularized human lipoaspirate. Acta Biomater 2011; 7: 1040-9.
163. Tan H, Ramirez CM, Miljkovic N, Li H, Rubin JP, Marra KG. Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering. Biomaterials 2009; 30: 6844-53.
164. Moyer HR, Kinney RC, Singh KA, Williams JK, Schwartz Z, Boyan BD. Alginate Microencapsulation Technology for the Percutaneous Delivery of Adipose-Derived Stem Cells. Ann Plast Surg 2010; 65: 229.
165. Chung HJ, Jung JS, Park TG. Fabrication of Adipose-Derived Mesenchymal Stem Cell Aggregates using Biodegradable Porous Microspheres for Injectable Adipose Tissue Regeneration. J Biomater Sci Polym Ed 2011; 22: 107-22.
166. Giordano C, Albani D, Gloria A, et al. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies. Int J Artif Organs. 2009; 32: 836-50.
167. Nisbet DR, Crompton KE, Horne MK, Finkelstein DI, Forsythe JS. Neural tissue engineering of the CNS using hydrogels. J Biomed Mater Res B Appl Biomat 2008; 87B: 251-63.
168. Martin BC, Minner EJ, Wiseman SL, Klank RL, Gilbert RJ. Agarose and methylcellulose hydrogel blends for nerve regeneration applications. J Neural Eng 2008; 5: 221-31.
169. Barnes SR, Walker DR, Goldberg EP. Injectable Cell-Biopolymer Gels for Neural Tissue Repair. 25th Southern Biomedical Engineering Conference 2009; Springer Verlag.
170. Ballios BG, Cooke MJ, van DK, Shoichet MS. A hydrogelbased stem cell delivery system to treat retinal degenerative diseases. Biomaterials 2010; 31: 2555-64.
171. Fitzpatrick SD, Jafar Mazumder MA, Lasowski F, Fitzpatrick LE, Sheardown H. PNIPAAm-Grafted-Collagen as an injectable, in situ gelling, bioactive cell delivery scaffold. Biomacromolecules 2010; 11: 2261-67.
172. Perale G, Giordano C, Bianco F, et al. Hydrogel for cell housing in the brain and in the spinal cord. Int J Artif Organs 2011; 34: 295-303.
173. Ashton RS, Banerjee A, Punyani S, Schaffer DV, Kane RS. Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials 2007; 28: 5518-25.
174. Singelyn JM, DeQuach JA, Seif-Naraghi S, Littlefield RB, Schup-Magoffin P, Christman KL. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials 2009; 30: 5409-16.
175. Seif-Naraghi S, Salvatore MA, Schup-Magoffin P, Hu DP, Christman KL., Design and characterization of an injectable pericardial matrix gel: A potentially autologous scaffold for cardiac tissue engineering. Tissue Eng Part A 2010; 16: 2017-27.
176. Barsotti MC, Felice F, Balbarini A, Di Stefano R. Fibrin as a scaffold for cardiac tissue engineering. Biotechnol Appl Biochem 2011; 58: 301-10.
177. Habib M, Shapira-Schweitzer K, Caspi O, et al. A combined cell therapy and in-situ tissue-engineering approach for myocardial repair. Biomaterials 2011; 32: 7514-23.
178. Chiu LLY, Janic K, Radisic M. Engineering of oriented myocardium on three-dimensional micropatterned collagenchitosan hydrogel. Int J Artif Organs 2012; 35: 237-50.
179. Bidarra SJ, Barrias CC, Fonseca KB, Barbosa MA, Soares RA, Granja PL. Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 2011; 32: 7897-904.
180. Rustad KC, Wong VW, Sorkin M, et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012; 33: 80-90.
181. Ryu JH, Kim I, Cho S, et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005; 26: 319-26.
182. Suuronen EJ, Veinot JP, Wong S, et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 2006; 114: 138-44.
183. Lu WN, Lü SH, Wang HB, et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A 2009; 15: 1437-47.
184. Wang F, Li Z, Khan M, et al. Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers. Acta Biomater 2010; 6: 1978-91.
185. Zhang X, Wang H, Ma X, et al. Preservation of the cardiac function in infarcted rat hearts by the transplantation of adipose-derived stem cells with injectable fibrin scaffolds. Exp Biol Med (Maywood) 2010; 235: 1505-15.
186. Tang ZCW, Liao W, Tang ACL, Tsai S, Hsieh PCH. The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan. Biomaterials 2011; 32: 75-86.
187. Wu LQ, Bentley WE, Payne GF., Biofabrication with biopolymers and enzymes: Potential for constructing scaffolds from soft matter. Int J Artif Organs 2011; 34: 215-24.
188. García Cruz DM, Escobar Ivirico JL, Gomes MM, et al. Chitosan microparticles as injectable scaffolds for tissue engineering. J Tissue Eng Regen Med 2008; 2: 378-80.
189. Sakai S, Hirose K, Taguchi K, Ogushi Y, Kawakami K. An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering., Biomaterials 2009; 30: 3371-7.
190. Lee W, Chang Y, Yeh Y, et al. The use of injectable spherically symmetric cell aggregates self-assembled in a ther- mo-responsive hydrogel for enhanced cell transplantation. Biomaterials 2009; 30: 5505-13.
191. Chiu Y, Chen S, Su C, et al. pH-triggered injectable hydrogels prepared from aqueous N-palmitoyl chitosan: In vitro characteristics and in vivo biocompatibility. Biomaterials 2009; 30: 4877-88.
192. Yucel T, Cebe P, Kaplan DL. Vortex-Induced Injectable Silk Fibroin Hydrogels. Biophys J 2009; 97: 2044-50.
193. Lau TT, Wang C, Wang D. Cell delivery with genipin crosslinked gelatin microspheres in hydrogel/microcarrier composite. Compos Sci Technol 2010; 70: 1909-14.
194. Kuwahara K, Yang Z, Slack GC, Nimni ME, Han B. Cell delivery using an injectable and adhesive transglutaminasegelatin gel. Tissue Eng Part C Methods 2010;16: 609-18.
195. Zhao L, Tang M, Weir MD, Detamore MS, Xu HHK. Os- teogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold. Tissue Eng Part A 2011; 17: 969-79.
196. Geutjes PJ, Faraj KA, Daamen WF, van Kuppevelt TH. Preparation of differently sized injectable collagen micro-scaffolds. J Tissue Eng Regen Med 2011; 5: 665-7.
197. Choh S, Cross D, Wang C. Facile Synthesis and Characterization of Disulfide-Cross-Linked Hyaluronic Acid Hydrogels for Protein Delivery and Cell Encapsulation. Biomacromolecules 2011; 12: 1126-36.
198. Prestwich GD. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine. J Control Release 2011; 155: 193-9.